k.nyberg
Submits third-party assay reports on material purchased directly. Based in Lagos.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.94%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042510 | IGF-1 LR3 | Homopeptide | HOMO-2607-P5131 | Janoshik | 2026-Q3 | 99.00 | 6.36 | 95.0 | Buyer-sourced | 0 | FAIL |
| AX-2026-043269 | IGF-1 LR3 | CPC | CPC-2512-S1358 | Medutest | 2026-Q2 | 98.29 | 2.59 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041345 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | Janoshik | 2026-Q1 | 99.57 | 5.91 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041499 | Semaglutide | QSC | QSC-2509-Y6202 | Janoshik | 2026-Q1 | 99.39 | 4.77 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019410 | MGF | HYB | HYB-2509-X7841 | Janoshik | 2025-Q4 | 99.72 | 2.19 | 107.1 | Buyer-sourced | 0 | PASS |
| AX-2025-018929 | Tirzepatide | TFS | TFS-{CAT}-9918 | Janoshik | 2025-Q2 | 96.84 | 5.52 | 103.0 | Buyer-sourced | 1 | FAIL |
| AX-2025-019188 | Tirzepatide | SinoPep | SNP-2411-Y4474 | Janoshik | 2025-Q2 | 98.29 | 3.81 | 101.8 | Buyer-sourced | 0 | PASS |
| AX-2025-020331 | BPC-157 | GGPeps | GGPE-2411-V3137 | Janoshik | 2025-Q2 | 98.89 | 3.10 | 104.8 | Buyer-sourced | 0 | PASS |